trending Market Intelligence /marketintelligence/en/news-insights/trending/vdculn1x7cs5ve-ou5y20g2 content esgSubNav
In This List

ChromaDex chairman to retire

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


ChromaDex chairman to retire

Steve Allen intends to retire as chairman and a director of ChromaDex Corp.

Allen, who is stepping down after four years of service, will not stand for re-election as a director at the company's annual meeting in June.